2024 Semi-Annual Results Briefing Investor Relations Activity Record Form
Tianxin Pharmaceutical: Announcement on the progress of repurchasing the company\'s shares through centralized bidding transactions
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on holding the 2024 semi-annual results briefing
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
2024 Semi-Annual Report
Announcement on operating data for the second quarter of 2024
Announcement of Resolutions of the Fifth Meeting of the Third Board of Supervisors
2024 Semi-Annual Report Summary
Announcement of Resolutions of the Fifth Meeting of the Third Board of Directors
Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Announcement on the adjustment of the maximum repurchase price after the implementation of the 2023 annual equity distribution.
CITIC Securities Co., Ltd.'s verification opinion on differentiated equity distribution matters of Jiangxi Tianxin Pharmaceutical Co., Ltd.
Announcement of Annual Equity Distribution Implementation in 2023
Company bylaws
Announcement regarding the completion of industrial and commercial change registration and issuance of business license.
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
2023 and 2024 First Quarter Results Briefing Investor Relations Activity Record Form
No Data
No Data